Literature DB >> 18045971

Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos.

Xiao-Yan Wang1, Yu Lan, Wen-Yan He, Lei Zhang, Hui-Yu Yao, Chun-Mei Hou, Ying Tong, Yuan-Lin Liu, Guan Yang, Xiao-Dan Liu, Xiao Yang, Bing Liu, Ning Mao.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells that can generate various microenvironment components in bone marrow, ensuring a precise control over self-renewal and multilineage differentiation of hematopoietic stem cells. Nevertheless, their spatiotemporal correlation with embryonic hematopoiesis remains rudimentary, particularly in relation to the human being. Here, we reported that human aorta-gonad-mesonephros (AGM) resided with bona fide MSCs. They were highly proliferative as fibroblastoid population bearing uniform surface markers (CD45(-), CD34(-), CD105(+), CD73(+), CD29(+), and CD44(+)), expressed pluripotential molecules Oct-4 and Nanog, and clonally demonstrated trilineage differentiation capacity (osteocytes, chondrocytes, and adipocytes). The frequency and absolute number of MSCs in aorta plus surrounding mesenchyme (E26-E27) were 0.3% and 164, respectively. Moreover, they were functionally equivalent to MSCs from adult bone marrow, that is, supporting long-term hematopoiesis and suppressing T-lymphocyte proliferation in vitro. In comparison, the matching yolk sac contained bipotent mesenchymal precursors that propagated more slowly and failed to generate chondrocytes in vitro. Together with previous knowledge, we propose that a proportion of MSCs initially develop in human AGM prior to their emergence in embryonic circulation and fetal liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045971     DOI: 10.1182/blood-2007-07-099333

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis.

Authors:  Erin E Kohler; Colleen E Cowan; Ishita Chatterjee; Asrar B Malik; Kishore K Wary
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

2.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone.

Authors:  Heng Zhu; Zi-Kuan Guo; Xiao-Xia Jiang; Hong Li; Xiao-Yan Wang; Hui-Yu Yao; Yi Zhang; Ning Mao
Journal:  Nat Protoc       Date:  2010-02-25       Impact factor: 13.491

Review 3.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

4.  Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.

Authors:  Hao Daniel Lin; Ariff Bongso; Kalamegam Gauthaman; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

5.  Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.

Authors:  Hao Daniel Lin; Chui Yee Fong; Arijit Biswas; Mahesh Choolani; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

6.  Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.

Authors:  Daniel Hao Lin; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

7.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

8.  Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton's Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus.

Authors:  Chiou-Mee Kong; Arjunan Subramanian; Arijit Biswas; Walter Stunkel; Yap-Seng Chong; Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

9.  Low-dose 6-bromoindirubin-3'-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization.

Authors:  Erin E Kohler; Jugajyoti Baruah; Norifumi Urao; Masuko Ushio-Fukai; Tohru Fukai; Ishita Chatterjee; Kishore K Wary
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

10.  Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cells.

Authors:  Stefan Radtke; André Görgens; Bing Liu; Peter A Horn; Bernd Giebel
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.